Evaluation of Pregnancy Outcomes in Iranian Women with Uterine Myomas
Novelty in Biomedicine,
Vol. 8 No. 3 (2020),
13 July 2020
,
Page 142-145
https://doi.org/10.22037/nbm.v8i3.29806
Abstract
Background: To investigate the impacts of myomas on the outcomes of pregnancy in Iranian pregnant women with uterine fibroids.Materials and Methods: In this retrospective cohort study, the consequences of myomas on pregnancy were investigated in Iranian pregnant women referred to the perinatology clinic of Mahdieh Hospital (Tehran, Iran). One-hundred and sixty pregnant women diagnosed with uterine myoma were enrolled in the study as the case group. The control group consisted of 160 pregnant women without fibroma. The characteristics of the myomas and their relationships with pregnancy outcomes were surveyed.
Results: Non-cephalic presentation, preterm labor, and Cesarean delivery were significantly higher in the case group in comparison with the control group. 106 patients (66.7%) had myomas larger than 5 cm in diameter. Intramural fibroids were seen in 132 (83%) patients. In addition, 133 (83.6%) patients had myomas in the body (corpus) of the uterus. Considering the number of myomas, 124 (78%) patients revealed one myoma in uterus. Uterine myomas during pregnancy rendered an important risk factor for cesarean delivery, breech presentation, and preterm delivery. However, there were no significant correlations between uterine myomas and IUGR, premature membranes rupture, either abortion or bleeding in the first trimester, low birth weight, and severe postpartum bleeding.
Conclusion: Our results showed that the presence of myoma could modulate pregnancy outcomes. Our results can be useful in improving the quality of prenatal care and education.
- Uterine Fibroids; Myoma; Pregnancy Outcomes;
How to Cite
References
Mettler L. Complications of uterine fibroids and their management, surgical management of fibroids, laparoscopy and hysteroscopy versus hysterectomy, haemorrhage, adhesions, and complications. Obstetrics and gynecology international; 2012. 2012.
Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best practice & research Clinical Obstetrics & Gynaecology. 2008;22(4):571-88.
Stewart EA. Epidemiology of uterine fibroids: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. 2017;124(10):1501-12.
Bray, M.J., Evaluating Epidemiologic and Genetic Risk Factors for Uterine Fibroid Characteristics; 2018.
Baird DD. A prospective, ultrasound-based study to evaluate risk factors for uterine fibroid incidence and growth: methods and results of recruitment. Journal of Women's Health. 2015;24(11):907-15.
Khan AT, Shehmar M, Gupta JK. Uterine fibroids: current perspectives. International Journal of Women's Health. 2014;6:95.
Hehenkamp J. Symptomatic uterine fibroids: treatment with uterine artery embolization or hysterectomy—results from the randomized clinical Embolisation versus Hysterectomy (EMMY) Trial. Radiology. 2008;246(3):823-32.
van der Kooij SM. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. American journal of obstetrics and gynecology; 2010;203(2):105.
Bajekal N,. Li T. Fibroids, infertility and pregnancy wastage. Human Reproduction Update. 2000;6(6):614-20.
Parazzini F, Tozzi L, Bianchi S. Pregnancy outcome and uterine fibroids. Best practice & research Clinical Obstetrics & Gynaecology. 2016;34:74-84.
Ciavattini A. Number and size of uterine fibroids and obstetric outcomes. The journal of maternal-fetal & neonatal medicine. 2015;28(4):484-8.
Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstetrics & Gynecology. 2000;95(5):764-9.
Hashemnezhad M. Obstetric outcomes in pregnant women with and without uterine leiomyoma; 2008.
- Abstract Viewed: 263 times
- PDF Downloaded: 5035 times